Bisht, Savita <br/><br/>
Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.  [electronic resource] 

 -  Molecular cancer therapeutics  Aug 2010 
 - 2255-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-10-0172  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biological Availability<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Curcumin--administration & dosage<br/>Cyclin D1--metabolism<br/>Deoxycytidine--analogs & derivatives<br/>Disease Models, Animal<br/>Down-Regulation--drug effects<br/>Drug Synergism<br/>Humans<br/>Matrix Metalloproteinase 9--metabolism<br/>Mice<br/>NF-kappa B--metabolism<br/>Nanoparticles--administration & dosage<br/>Neoplasm Metastasis--pathology<br/>Pancreatic Neoplasms--drug therapy<br/>Polymers--administration & dosage<br/>Subcutaneous Tissue--drug effects<br/>Xenograft Model Antitumor Assays<br/>Gemcitabine